Literature DB >> 2142146

Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease.

K Norose1, A Yano, F Aosai, K Segawa.   

Abstract

In this study, we focused upon the immunologic aspects of Vogt-Koyanagi-Harada disease (VKH) by comparing the cytotoxic activity of peripheral blood leukocytes (PBL) to that of cerebrospinal fluid leukocytes (CSFL) against the human melanoma cell line (P-36) and the human cervical carcinoma cell line (HeLa-S3). The PBL from patients with VKH showed significant cytotoxic activity against P-36 (P less than 0.01), but did not show cytotoxic activity against HeLa-S3. The CSFL showed significantly weaker cytotoxic activity against P-36 compared to that of PBL (P less than 0.02). We also analyzed the cell membrane surface markers applying monoclonal antibodies on PBL and CSFL. The percentage of OKT8+ (CD8: T cytotoxic/suppressor lymphocytes) cells was significantly lower in CSFL than in PBL (P less than 0.05). There was a tendency toward a higher percentage of HLA-DR+ cells (B lymphocytes, monocytes, macrophages, and activated T lymphocytes) and a higher ratio of OKT4+/8+ cells (CD4/CD8: T helper/inducer lymphocytes/T cytotoxic/suppressor lymphocytes) in CSFL from patients with VKH than in their PBL (P less than 0.1).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142146

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Authors:  K Norose; A Yano
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

2.  Incomplete Vogt-Koyanagi-Harada in a 14-year-Old African American female with bilateral disc edema.

Authors:  Yasaman Ataei; Wasim A Samara; Warren L Felton; Vikram S Brar
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-02

3.  Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells.

Authors:  M Bonacini; L Cimino; L De Simone; E Bolletta; F Gozzi; A Soriano; F Muratore; A Zerbini; L Fontana; C Salvarani; S Croci
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

4.  Identification of differently expressed mRNAs by peripheral blood mononuclear cells in Vogt-Koyanagi-Harada disease.

Authors:  Yujing Li; Guannan Su; Fanfan Huang; Ying Zhu; Xiang Luo; Aize Kijlstra; Peizeng Yang
Journal:  Genes Dis       Date:  2021-06-30

Review 5.  Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.

Authors:  Carl P Herbort; Ilknur Tugal-Tutkun; Ahmed Abu-El-Asrar; Amod Gupta; Masaru Takeuchi; Christine Fardeau; Alireza Hedayatfar; Cristhian Urzua; Ioannis Papasavvas
Journal:  Eye (Lond)       Date:  2021-06-18       Impact factor: 3.775

Review 6.  miRNA Landscape in Pathogenesis and Treatment of Vogt-Koyanagi-Harada Disease.

Authors:  Fabian Vega-Tapia; Mario Bustamante; Rodrigo A Valenzuela; Cristhian A Urzua; Loreto Cuitino
Journal:  Front Cell Dev Biol       Date:  2021-05-10

7.  Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.

Authors:  Carl P Herbort; Manabu Mochizuki
Journal:  Int Ophthalmol       Date:  2007-04-28       Impact factor: 2.029

8.  Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.

Authors:  Sébastien Abad; Grégoire Wieërs; Didier Colau; Claude Wildmann; Emmanuelle Delair; Robin Dhote; Antoine P Brézin; Yukata Kawakami; Pierre G Coulie; Pierre van der Bruggen
Journal:  Mol Vis       Date:  2014-07-02       Impact factor: 2.367

Review 9.  Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.

Authors:  Marcelo Mendes Lavezzo; Viviane Mayumi Sakata; Celso Morita; Ever Ernesto Caso Rodriguez; Smairah Frutuoso Abdallah; Felipe T G da Silva; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

10.  Pregnancy-induced hypertension-related chorioretinitis resembling uveal effusion syndrome: A case report.

Authors:  Tomohito Sato; Masaru Takeuchi
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.